Low-level arsenite induced gene expression in HEK293 cells

Toxicology

Volumn 187, Issue 1, 2003, Pages 39-48

  Zheng, Xing Hui ^a   Watts, George S ^b   Vaught, Skip ^b   Gandolfi, A Jay ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Arsenite; cDNA microarray; Gene expression profiling; HEK293 cells

Indexed keywords

ARSENIC TRIOXIDE; CHEMOKINE RECEPTOR; COMPLEMENTARY DNA; METALLOTHIONEIN; PROTEINASE; TRANSCRIPTION FACTOR;

ADAPTATION; ARTICLE; CELL DAMAGE; CELL LINE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HYBRIDIZATION; INCUBATION TIME; KIDNEY CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTO ONCOGENE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TARGET ORGAN;

EID: 0345505337     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(03)00025-8     Document Type: Article

References (33)

1. Basu A., Matasha J., Gupta S., Giri A.K. Genetic toxicology of a paradoxical human carcinogen, arsenic: a review. Mutat. Res. 488:2001;171-194.
2. Chen H., Liu J., Merrick B.A., Waalkes M.P. Genetic events associated with arsenic-induced malignant transformation: application of cDNA microarray technology. Mol. Carcinog. 30:(2):2001;79-87.
3. Chou W.-C., Hawkins A.L., Barrett J.F., Griffin C.A., Dang C.V. Arsenic inhibition of telomerase transcription leads to genetic instability. J. Clin. Invest. 108:2001;1541-1547.
4. Cohen S.M., Arnold L.L., Uzvolgyi E., Cano M., John M.S., Yamamono S., Lu X.F., Le X.C. Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat. Chem. Res.Toxicol. 15:2002;1150-1157.
5. Corsini E., Asti L., Viviani B., Marinovich M., Galli C.L. Sodium arsenate induces overproduction of interleukin-1α in murine keratinocytes: role of mitochondria. J. Invest. Dermatol. 113:1999;760-765.
6. Del Razo L.M., Quintanilla-Vega B., Brambila-Colombres E., Calderon-Aranda E.S., Manno M., Albores A. Stress proteins induced by arsenic. Toxicol. Appl. Pharmacol. 177:2001;132-148.
7. Denison M.S., Whitlock J.P. Jr. Xenobiotic-inducibble transcription of cytochrome P-450 genes. J. Biol. Chem. 270:(31):1995;18175-18178.
8. Frueh F.W., Hayashibara K.C., Brown P.O., Whitlock J.P. Jr. Use of cDNA microarrays to analyze dioxin-induced changes in human liver gene expression. Toxicol. Lett. 122:2001;189-203.
9. Goering P.L., Aposhian H.V., Mass M.J., Cebrian M., Beck B.D., Waalkes M.P. The enigma of arsenic carcinogenesis: role of metabolism. Toxicol. Sci. 49:1999;5-14.
10. Hamadeh K.H., Trouba K.J., Amin R.P., Afshari C.A., Germolec D. Coordination of altered DNA repair and damage pathways in arsenite-axposed keratinocytes. Toxicol. Sci. 69:2002;306-316.
11. Hamilton J.W., Kaltreider R.C., Bajenova O.V., Ihnat M.A., McCaffrey J., Turpie B.W., Rowell E.E., Oh J., Nemeth M.J., Pesce C.A., Lariviere J.P. Molecular basis for effects of carcinogenic heavy metals on inducible gene expression. Environ. Health Perspect. 106:(Suppl.):1998;1005-1015.
12. Hayes R.B. The carcinogencity of metals in humans. Cancer Causes Control. 8:1997;371-385.
13. Keith R.L., McGuinness S.J., Gandolfi A.J., Lowe T.P., Chen Q., Fernando Q. Interaction of metals during their uptake and accumulation in rabbit renal cortical slices. Environ. Health Perspect. 103:1995;77-80.
14. Kirkpatrick D.S., Dale K.V., Catania J.M., Gandolfi A.J. Subtoxic arsenite causes accumulation of ubiquitinated proteins in HEK293 cells and rabbit renal slices. Toxicol. Appl. Pharmacol. 186:(2):2003;101-109.
15. Klaassen C.D. Effect of metallothionein on hepatic disposition of metals. Am. J. Physiol. 234:1978;E47-E53.
16. Kreppel H., Bauman J.W., Liu J., McKim J.M. Jr, Klaassen C.D. Induction of metallothionein by arsenicals in mice. Fundam. Appl. Toxicol. 20:1993;184-189.
17. Lavrovsky Y., Song C.S., Chatterjee B., Roy A.K. Age-dependent increase of heme oxygenase-1 gene expression in the liver mediated by NF-κB. Mech. Ageing Dev. 114:2000;49-60.
18. Lin T.H., Huang Y.L., Wang M.Y. Arsenic species in drinking water, hair, fingernails, and urine of patients with blackfoot disease. J. Toxicol. Environ. Health. 5:1998;85-93.
19. Liu J., Kadiiska M.B., Liu Y., Lu T., Qu W., Waalkes M.P. Stress-related gene expression in mice treated with inorganic arsenicals. Toxicol. Sci. 61:(2):2001;314-320.
20. Lynn S., Gurr J.-R., Lai H.-T., Jan K.-Y. NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circ. Res. 86:2000;514-519.
21. Menzel D.B., Rasmussen R.E., Lee E., Meacher D.M., Hamudeh H., Vargas M., Greene H., Roth R.N. Human lymphocyte heme oxygenase as a biomarker to inorganic arsenic. Biochem. Biophys. Res. Commun. 250:1998;653-656.
22. Muller R.M., Taguchi H., Shibahara S. Nucleotide sequence and organization of rat heme-oxygenase gene. J. Biol. Chem. 14:1987;6795-6802.
23. Okey A.B. Enzyme induction in the cytochrome P-450 system. Pharmacol. Ther. 45:(2):1990;241-298.
24. Parrish A.R., Zheng X.-H., Turney K.D., Younis H.S., Gandolfi A.J. Enhanced transcription factor DNA binding and gene expression induced by arsenite or arsenate in renal slices. Toxicol. Sci. 50:1999;98-105.
25. Porter A.C., Fanger G.R., Vaillancourt R.R. Signal transduction pathways regulated by arsenate and arsenite. Oncogene. 18:(54):1999;7794-7802.
26. Schlenk D., Wolford L., Chelius M., Steevens J., Chan K.M. Effect of arsenite, arsenate, and the herbicide monosodium methyl arsonate (MSMA) on hepatic metallothionein expression and lipid peroxidation in channel catfish. Comp. Biochem. Physiol. Cpharmacol. Toxicol. Endocrinol. 118:1997;177-183.
27. Schuliga M., Chouchane S., Snow E.T. Upregulation of glutathione-related genes and enzyme activities in cultured human cells by sublethal concentrations of inorganic arsenic. Toxicol. Sci. 70:2002;183-192.
28. Styblo M., Del Razo L.M., Vega L., Germolec D.R., Lecluyse E.L., Hmilton G.A., Reed W., Wang C., Cullen W.R., Thomas D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arseniccals in rat and human cells. Arch. Toxicol. 74:2000;289-299.
29. Tchounwou P.B., Wilson B.A., Ishaque A.B., Schneider J. Atrezine potentiation of arsenic trioxide-induced cytotoxicity and gene expression in human liver carcinoma cells (HepG2). Mol. Cell. Biochem. 222:(1-2):2001;49-59.
30. Watts G.S., Futscher B.W., Isett R., Gleason-Guzman M., Kunkel M.W., Salmon S.E. cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways. J. Pharm. Exp. Thera. 299:(2):2001;434-441.
31. Wiencke C.K., Yager J.W., Varkonyi A., Hultner M., Lutze L.H. Study of arsenic mutagenesis using the plasmid shuttle vector pZ189 propagated in DNA repair proficient human cells. Mutat. Res. 386:1997;335-344.
32. Wijeweera J.B., Gandolfi A.J., Parrish A., Lantz R.C. Sodium arsenite enhances AP-1 and NF-κB DNA binding and induces stress protein expression in precision-cut rat lung slices. Toxicol. Sci. 61:2001;283-294.
33. Yih L.-H., Peck K., Lee T.-C. Changes in gene expression profiles of human fibroblasts in response to sodium arsenite treatment. Carcinogenesis. 23:(5):2002;867-876.